Search Results - "Faich, G A"

Effect of onychomycosis on quality of life by Drake, Lynn A., Scher, Richard K., Smith, Edgar B., Faich, Gerald A., Smith, Shondra L., Hong, Joseph J., Stiller, Matthew J.

“…Background: Onychomycosis impairs normal nail functions, causes considerable pain, interferes with daily activities, and has negative psychosocial effects…”
Get full text

Pharmacotherapy for Obesity — Do the Benefits Outweigh the Risks? by Manson, JoAnn E, Faich, Gerald A

“…An association between appetite-suppressant drugs and primary pulmonary hypertension is reported by Abenhaim et al. in this issue of the Journal . 1 This…”
Get full text

Effects of exposure to benzodiazepine during fetal life by Bergman, U, Rosa, F W, Baum, C, Wiholm, B E, Faich, G A

“…Dysmorphism and mental retardation have been reported in 7 Swedish children born of mothers who had taken high doses of benzodiazepines regularly during…”
Get more information

Blood-pressure-lowering treatment by Faich, Gerald A, Makuch, Robert

Get full text

Drug to treat obesity: editorial writer responds by Faich, G A

Get full text

National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985 by ARROWSMITH, J. B, KENNEDY, D. L, KURITSKY, J. N, FAICH, G. A

“…The number of cases of Reye syndrome reported annually to the Centers for Disease Control declined markedly between 1980 and 1985. In this article, we present…”
Get full text

Conflicts of Interest — Editorialists Respond by Manson, JoAnn E, Faich, Gerald A

“…To the Editor: We appreciate the opportunity to present our perspective on the events surrounding the publication in the Journal of our editorial…”
Get full text

Troglitazone (Rezulin) and hepatic injury by Faich, Gerald A., Moseley, Richard H.

“…Purpose Analyze US rates of reported severe liver disease for the oral hypoglycemic agent troglitazone from March 1997 through February 2000 and the possible…”
Get full text

Morbidity and mortality among low birth weight infants exposed to an intravenous vitamin E product, E-Ferol by Arrowsmith, J.B, Faich, G.A, Tomita, D.K, Kuritsky, J.N, Rosa, F.W

“…In April 1984, the US FDA was notified of an unusual clinical syndrome consisting of ascites, liver and renal failure, thrombocytopenia, and death among low…”
Get full text

An epidemiologic study of the risks associated with peripheral intravenous catheters by Tager, I B, Ginsberg, M B, Ellis, S E, Walsh, N E, Dupont, I, Simchen, E, Faich, G A

“…As part of a standardized, multi-hospital prospective surveillance system for nosocomial infections in Rhode Island, an analysis was undertaken in March…”
Get more information

Incidence and hospitalization patterns of insulin-dependent diabetes mellitus by Fishbein, H A, Faich, G A, Ellis, S E

“…Incidence and hospitalization patterns of insulin-dependent diabetes mellitus. H A Fishbein , G A Faich and S E Ellis Abstract Data from a statewide…”
Get full text

National Adverse Drug Reaction Surveillance: 1985 by Faich, Gerald A, Knapp, Deanne, Dreis, Michael, Turner, Wayne

“…The Food and Drug Administration received about 37000 adverse drug reaction reports in 1985. Seventy-one percent of the reports involved toxic reactions to…”
Get full text

Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine by Jolson, H M, Bosco, L, Bufton, M G, Gerstman, B B, Rinsler, S S, Williams, E, Flynn, B, Simmons, W D, Stadel, B V, Faich, G A

“…Cerebellar toxicity is a severe, therapy-limiting adverse reaction of cytarabine given in high doses. The Food and Drug Administration received a report of an…”
Get more information

Risks and indications of phenylbutazone: another look by Faich, G A

“…In 1984 an extensive review of phenylbutazone risks was undertaken by the Food and Drug Administration (FDA). Since that review, new recommendations for the…”
Get more information

Diarrhea after misoprostol in Crohn disease by Faich, G A, Frick, M F, Koffer, H

Get more information

Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III by Kuritsky, J N, Rastogi, S C, Faich, G A, Schorr, J B, Menitove, J E, Reilly, R W, Bove, J R

“…From April 22 to July 28, and from October 7 to November 3, 1985 the American Red Cross, the Council of Community Blood Centers, the American Association of…”
Get more information

Physician Reporting of Adverse Drug Reactions: Results of the Rhode Island Adverse Drug Reaction Reporting Project by Scott, H. Denman, Thacher-Renshaw, Ann, Rosenbaum, Sara E, Waters, William J, Green, Marilyn, Andrews, Lisa G, Faich, Gerald A

“…The Food and Drug Administration, Rockville, Md, contracted with the Rhode Island Department of Health, Providence, to conduct a project to increase reporting…”
Get full text

Adverse-drug-reaction monitoring by Faich, G A

Get more information

Asbestos hazard evaluation in Rhode Island schools by Faich, G A

“…A statewide survey to identify and abate spray-on asbestos hazards in schools has been conducted in Rhode Island. Of 326 target schools, 24 (8 per cent)…”
Get full text

National adverse drug reaction reporting. 1984-1989 by Faich, G A

“…Surveillance of adverse reactions due to pharmaceuticals is important because the drug approval process cannot totally assure safety and because new knowledge…”
Get more information